Please ensure Javascript is enabled for purposes of website accessibility U.S. Financial Professionals | Janus Henderson Investors

Global Small Cap – strategy update

Nick Sheridan, Portfolio Manager on the European Equities team, on Tuesday 24 September delivered a quarterly update on the Global Small Cap strategy, as well as sharing the latest market perspectives and outlook.

Tim Walbert

Tim Walbert is currently senior advisor, Amgen. Most recently, Mr. Walbert served as the chairman, president and chief executive officer of Horizon Therapeutics from 2008 to October 2023, when it was acquired by Amgen for $28.3 billion. Before joining Horizon, he was president, chief executive officer and director of IDM Pharma Inc., a public biotechnology

John King

John King is an Associate Portfolio Manager on the Diversified Alternatives Team at Janus Henderson Investors, a position he has held since 2024.

Richard Romer-Lee

Richard is a co-founder of Square Mile and is responsible for determining the strategy and focus for the business in conjunction with the Board and the Management Team. He works closely with clients, as well forging strong business relationships within the wider industry. Richard regularly interviews leading industry figures for Square Mile’s popular ‘Talking With’ series.